Tecentriq 1 200 mg concentrate for solution for infusion, PACLITAXEL, CARBOPLATIN
IFCT-1805
Phase 3 small_molecule active
Quick answer
Tecentriq 1 200 mg concentrate for solution for infusion, PACLITAXEL, CARBOPLATIN for Non Small Cell Lung Cancer is a Phase 3 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- Non Small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active